High circulating levels of the IGF-1R ligand IGF-1 can also activate IGF-1R signaling and is correlated with increased risk of prostate [43], ovarian [44], and breast cancer [45], as well as possibly second primary cancers [46]. This evidence concerns the gene IGF1R and breast carcinoma.